Filing Details
- Accession Number:
- 0001237899-19-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-26 16:02:28
- Reporting Period:
- 2019-11-22
- Accepted Time:
- 2019-11-26 16:02:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-14 | 40,681 | $0.00 | 347,824 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2019-11-21 | 7,246 | $0.00 | 340,578 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2019-11-22 | 46,138 | $21.25 | 386,716 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-22 | 23,989 | $358.33 | 362,727 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-11-22 | 14,000 | $0.00 | 348,727 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2019-11-25 | 22,093 | $0.00 | 326,634 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2019-11-25 | 156 | $358.92 | 326,478 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 1,479 | $359.46 | 324,999 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 592 | $360.37 | 324,407 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 2,492 | $361.46 | 321,915 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 2,284 | $362.61 | 319,631 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 3,605 | $363.53 | 316,026 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 3,755 | $364.55 | 312,271 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 3,269 | $365.25 | 309,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-25 | 4,517 | $366.63 | 304,485 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-07-02 | 669 | $0.00 | 145,661 | No | 5 | G | Indirect | by CLAT |
| Common Stock | Disposition | 2019-10-02 | 764 | $0.00 | 144,897 | No | 5 | G | Indirect | by CLAT |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Indirect | by CLAT |
| No | 5 | G | Indirect | by CLAT |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-11-22 | 46,138 | $0.00 | 46,138 | $21.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 107,655 | 2019-12-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,326 | Indirect | By 401(k) Plan |
| Common Stock | 83,652 | Indirect | by Spouse as Trustee |
| Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 156 shares of Company stock on November 25, 2019 at prices ranging from $358.68 to $358.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 1,479 shares of Company stock on November 25, 2019 at prices ranging from $359.05 to $359.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 592 shares of Company stock on November 25, 2019 at prices ranging from $360.01 to $360.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 2,492 shares of Company stock on November 25, 2019 at prices ranging from $361.06 to $361.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 25, 2019 at prices ranging from $362.02 to $362.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 3,605 shares of Company stock on November 25, 2019 at prices ranging from $363.00 to $363.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 3,755 shares of Company stock on November 25, 2019 at prices ranging from $364.04 to $364.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 3,269 shares of Company stock on November 25, 2019 at prices ranging from $365.02 to $365.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- Represents volume-weighted average price of sales of 4,517 shares of Company stock on November 25, 2019 at prices ranging from $366.07 to $366.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
